He added that each of the 10 benefiting communities received a cheque of $25,000 from the governor at the occasion. Mohammed listed the benefiting communities as Chiranchi, Diso, Kofar-Naisa, ...

Biogen Inc. (BIIB) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...

Fresh off a re­or­ga­ni­za­tion, Bio­gen’s re­search leader Jane Gro­gan says the biotech has to “look out­side the walls of the com­pa­ny” to avoid be­ing left … ...

Biogen BIIB and Japan-based partner, Eisai, announced an update regarding the regulatory review of an application seeking the approval of Leqembi (lecanemab) for mild cognitive impairment due to ...

s and Biogen Inc.’s medicine for Alzheimer’s disease, providing a response after a meeting next month. The drug, Leqembi, can slow the progression of Alzheimer’s, the mind-robbing disease ...

Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) are expected to face another delay in launching their new Alzheimer's drug, lecanemab, in the EU after the European Commission on Friday asked the ...

Investors in Biogen Inc (Symbol: BIIB) saw new options become available today, for the March 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB ...

Across the recent three months, 18 analysts have shared their insights on Biogen (NASDAQ:BIIB), expressing a variety of opinions spanning from bullish to bearish. The following table encapsulates ...

Sage’s board has stated it will consider “strategic alternatives” to maximise shareholder value. Credit: Bloomberg via Getty Images. Sage Therapeutics has rejected Biogen’s $469m takeover offer, with ...